Rosai-Dorfman Disease and Unusual Local Invasive Presentation.
rosai dorfman disease
sinus histiocytosis with massive lymphadenopathy
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
19 Mar 2020
19 Mar 2020
Historique:
entrez:
22
4
2020
pubmed:
22
4
2020
medline:
22
4
2020
Statut:
epublish
Résumé
Rosai-Dorfman disease (RDD) is a rare medical condition with bilateral painless lymphadenopathy. We present the case of a young man diagnosed with a very unique presentation of Rosai-Dorfman disease. A 40-year-old African-American man presented with a firm, non-tender, progressive chest and neck mass appeared three months ago. Imaging of the neck demonstrated an 8.6-cm anterior neck subcutaneous soft tissue mass extending into the anterior mediastinum through the sternum with erosive changes in the sternum and the lesion is abutting the right common carotid artery and innominate vein and surrounds the medial aspect of the clavicles bilaterally. Ultrasound (US)-guided biopsy showed marked polytypic-appearing plasma cell proliferation associated with relatively prominent histiocytes with hemophagocytosis/emperipolesis and focal neutrophils. There were S100+ histiocytes; however, findings were not typical for RDD. As that biopsy was not diagnostic, incisional biopsy with adequate sampling was performed. Surgical pathology demonstrated a very abnormal infiltrate with prominent histiocytes including areas with the features of extranodal RDD. BRAF V600E immunohistochemistry (IHC) was negative. Modified radical neck dissection, proximal sternal resection and superior mediastinal nodal dissection surgery was recommended. However, the patient refused the procedure. Typical manifestations are lymphadenopathy with fever that our patient did not experience. Bone involvement happens in 5-10% of cases. There is not enough data about blood vessel invasion which make our case unique. Treatment plan is still controversial. Clinical monitoring is recommended if the symptoms are tolerable as regression has been reported in many cases (20-50%). Surgery is reserved for patients with vital organ involvement or extra-nodal disease.
Identifiants
pubmed: 32313769
doi: 10.7759/cureus.7328
pmc: PMC7164721
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e7328Informations de copyright
Copyright © 2020, Mohammadi et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Acta Haematol. 2017;138(1):14-23
pubmed: 28614806
Ann Am Thorac Soc. 2016 May;13(5):666-70
pubmed: 26820713
Arch Craniofac Surg. 2016 Mar;17(1):31-34
pubmed: 28913250
Ann Thorac Surg. 2012 Dec;94(6):2118-20
pubmed: 23176929
Pediatr Radiol. 2008 Jul;38(7):721-8; quiz 821-2
pubmed: 18246343
Am J Hematol. 2002 Jan;69(1):67-71
pubmed: 11835335
Am J Clin Pathol. 2016 Feb;145(2):211-21
pubmed: 26803323
Ann Thorac Surg. 2009 Feb;87(2):616-8
pubmed: 19161795
Cent Eur J Immunol. 2018;43(3):341-345
pubmed: 30588179
Blood. 2018 Jun 28;131(26):2877-2890
pubmed: 29720485